Liquid Biopsy Market to Reach $2.7 Billion by 2029, Growing at a CAGR of 16.7%
Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Expected Total Market Size Of The Liquid Biopsy Industry By The Forecast Year 2029?
The liquid biopsy market has demonstrated rapid growth over recent years. It is projected to expand from $1.25 billion in 2024 to $1.46 billion in 2025, achieving a compound annual growth rate (CAGR) of 16.1%. Historically, this expansion has been driven by factors such as advances in cancer research, non-invasiveness, personalized medicine, regulatory approvals, and early cancer detection.
The liquid biopsy market is anticipated to experience significant expansion over the coming years. This market is projected to reach a valuation of $2.7 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 16.7%. Factors contributing to this growth during the forecast period include the broadening scope of applications, advancements in cancer monitoring, the emergence of new technologies, developments in companion diagnostics, and ongoing biomarker discovery efforts. Key developments expected during this period encompass improved cancer detection and monitoring, more effective therapeutic monitoring, the use of minimal residual disease (MRD) monitoring, and the application of liquid biopsy techniques in non-oncological fields.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2815&type=smp
Which Drivers Are Supporting Growth Of The Liquid Biopsy Market?
Government financial support aimed at refining cancer detection methods significantly propels the expansion of the liquid biopsy market. These public funds aid researchers in critical areas such as drug discovery, diagnosis, and the treatment of diseases like Cancer. For instance, in 2022, the National Institute of Health (NIH), a US-based medical research agency, was granted a fund of $46.6 billion, and an additional $6.9 billion was awarded to the National Cancer Institute (NCI), an American cancer research agency, specifically for advancing cancer research. Consequently, government funds demonstrably have a positive impact on the growth of the liquid biopsy market.
What Are The Segment Types Shaping The Liquid Biopsy Market?
The liquid biopsymarket covered in this report is segmented –
1) By Product: Assays Kits; Instruments; Services
2) By Clinical Application: Early Cancer Screening; Therapy Selection; Treatment Monitoring; Recurrence Monitoring Orthopedics
3) By End User: Reference Laboratories; Hospitals and Physician Laboratories; Academic and Research Centers
Subsegments:
1) By Assays Kits: cfDNA Assays; ctDNA Assays; Exosome-based Assays; RNA-based Assays; Protein-based Assays
2) By Instruments: PCR Instruments; Next-Generation Sequencing (NGS) Instruments; Microarray Instruments; Mass Spectrometry Instruments
3) By Services: Testing Services; Data Analysis Services; Laboratory Services; Custom Assay Development Services
How Are Emerging Market Trends Shaping The Liquid Biopsy Industry Landscape?
Businesses are quickly adapting to evolving market dynamics, primarily concentrating on advanced product introductions to satisfy the escalating demand for liquid biopsy products and services, enhance their revenue, and secure a competitive advantage over competitors. For instance, in June 2023, Laboratory Corporation of America Holdings, a US-based healthcare company, introduced Labcorp Plasma Focus, a liquid biopsy test. This test was developed to identify cancer-associated biomarkers in individuals with advanced or metastatic solid tumors. The examination analyzes the cell-free DNA (cfDNA) circulating in a patient’s blood sample to construct a genomic profile of their tumor. This empowers oncologists to improve the management of their patients’ healthcare by devising personalized, precisely targeted therapy strategies. Consequently, companies are investing in the development of advanced products in the liquid biopsy market.
Who Are The Primary Competitors In The Global Liquid Biopsy Market?
Major companies operating in the liquid biopsy market include QIAGEN NV, Roche Diagnostics Ltd., Bio-Rad Laboratories Inc., Myriad Genetics Inc., Guardant Health Inc., Thermo Fisher Scientific Inc., Menarini Silicon Biosystems, Biocept Inc., Janssen Diagnostics LLC, Trovagene Inc., Fraunhofer-Gesellschaft, MDX Health SA, Agilent Technologies Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Quantum Biosystems Inc., Menarini Silicon Biosystems Inc., Pathway Genomics Corporation, Sysmex Corporation, Janssen Global Services LLC, Natera Inc., ANGLE Plc, Bio Techne Corp, Biodesix Inc., CellMax Inc., CIRCULOGENE, Exact Sciences Corporation, Epic Sciences Inc., Exosome Diagnostics Inc., GRAIL Inc., Guardant Health AMEA, Inivata Ltd., NIPD Genetics, Oncocyte Corporation, Personal Genome Diagnostics Inc., RainDance Technologies Inc., Thrive Earlier Detection Corp.
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/liquid-biopsy-global-market-report
Which Regional Markets Are Contributing Most To The Liquid Biopsy Industry Expansion?
North America was the largest region in the liquid biopsy market in 2024. Western Europe was the second largest region in the liquid biopsy market. The regions covered in the liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Liquid Biopsy Market Report:
https://www.thebusinessresearchcompany.com/customise?id=2815&type=smp
Browse Through More Reports Similar to the Global Liquid Biopsy Market 2025, By The Business Research Company
Biophotonics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biophotonics-global-market-report
Biopsy Devices Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report
Ultrasound Systems Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.